155 related articles for article (PubMed ID: 35531010)
1. Construction of antifungal dual-target (SE, CYP51) pharmacophore models and the discovery of novel antifungal inhibitors.
Dong Y; Liu M; Wang J; Ding Z; Sun B
RSC Adv; 2019 Aug; 9(45):26302-26314. PubMed ID: 35531010
[TBL] [Abstract][Full Text] [Related]
2. Comparison and analysis of the structures and binding modes of antifungal SE and CYP51 inhibitors.
Sun B; Huang W; Liu M; Lei K
J Mol Graph Model; 2017 Oct; 77():1-8. PubMed ID: 28802152
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of amide-pyridine derivatives as novel dual-target (SE, CYP51) antifungal inhibitors.
Sun B; Dong Y; Lei K; Wang J; Zhao L; Liu M
Bioorg Med Chem; 2019 Jun; 27(12):2427-2437. PubMed ID: 30765301
[TBL] [Abstract][Full Text] [Related]
4. Construction and activity evaluation of novel benzodioxane derivatives as dual-target antifungal inhibitors.
An Y; Liu W; Xie H; Fan H; Han J; Sun B
Eur J Med Chem; 2022 Jan; 227():113950. PubMed ID: 34731761
[TBL] [Abstract][Full Text] [Related]
5. Novel naphthylamide derivatives as dual-target antifungal inhibitors: Design, synthesis and biological evaluation.
An Y; Dong Y; Liu M; Han J; Zhao L; Sun B
Eur J Med Chem; 2021 Jan; 210():112991. PubMed ID: 33183866
[TBL] [Abstract][Full Text] [Related]
6. Lanosterol 14α-demethylase (CYP51)/histone deacetylase (HDAC) dual inhibitors for treatment of Candida tropicalis and Cryptococcus neoformans infections.
Zhu T; Chen X; Li C; Tu J; Liu N; Xu D; Sheng C
Eur J Med Chem; 2021 Oct; 221():113524. PubMed ID: 33992927
[TBL] [Abstract][Full Text] [Related]
7. Construction and activity evaluation of novel dual-target (SE/CYP51) anti-fungal agents containing amide naphthyl structure.
Liu W; Sun Z; An Y; Liu Y; Fan H; Han J; Sun B
Eur J Med Chem; 2022 Jan; 228():113972. PubMed ID: 34772530
[TBL] [Abstract][Full Text] [Related]
8. Potent arylamide derivatives as dual-target antifungal agents: Design, synthesis, biological evaluation, and molecular docking studies.
Dong Y; Liu X; An Y; Liu M; Han J; Sun B
Bioorg Chem; 2020 Jun; 99():103749. PubMed ID: 32220664
[TBL] [Abstract][Full Text] [Related]
9. Structure-based virtual screening and ADME/T-based prediction analysis for the discovery of novel antifungal CYP51 inhibitors.
Sun B; Zhang H; Liu M; Hou Z; Liu X
Medchemcomm; 2018 Jul; 9(7):1178-1187. PubMed ID: 30109006
[TBL] [Abstract][Full Text] [Related]
10. Structural analyses of
Hargrove TY; Friggeri L; Wawrzak Z; Qi A; Hoekstra WJ; Schotzinger RJ; York JD; Guengerich FP; Lepesheva GI
J Biol Chem; 2017 Apr; 292(16):6728-6743. PubMed ID: 28258218
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and bioactivity evaluation of novel arylalkene-amide derivatives as dual-target antifungal inhibitors.
Sun B; Dong Y; An Y; Liu M; Han J; Zhao L; Liu X
Eur J Med Chem; 2020 Nov; 205():112645. PubMed ID: 32791399
[TBL] [Abstract][Full Text] [Related]
12. Construction and Evaluation of Molecular Models: Guide and Design of Novel SE Inhibitors.
An Y; Dong Y; Min L; Zhao L; Zhao D; Han J; Sun B
ACS Med Chem Lett; 2020 Jun; 11(6):1152-1159. PubMed ID: 32550995
[TBL] [Abstract][Full Text] [Related]
13. Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14α-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity.
Hargrove TY; Garvey EP; Hoekstra WJ; Yates CM; Wawrzak Z; Rachakonda G; Villalta F; Lepesheva GI
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461309
[TBL] [Abstract][Full Text] [Related]
14. Pyridylethanol(phenylethyl)amines are non-azole, highly selective Candida albicans sterol 14α-demethylase inhibitors.
Ogris I; Zelenko U; Sosič I; Gobec M; Skubic C; Ivanov M; Soković M; Kocjan D; Rozman D; Golič Grdadolnik S
Bioorg Chem; 2021 Jan; 106():104472. PubMed ID: 33261849
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
Ekins S; Mankowski DC; Hoover DJ; Lawton MP; Treadway JL; Harwood HJ
Drug Metab Dispos; 2007 Mar; 35(3):493-500. PubMed ID: 17194716
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 1,2,3-selenadiazole analogues as antifungal agents using a scaffold hopping approach.
Xu H; Cao C; Wang X; Guo MB; Yan ZZ; An R; Zhang R; Dong EH; Mou YH; Hou Z; Guo C
Bioorg Chem; 2021 Oct; 115():105182. PubMed ID: 34333426
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and antifungal activities in vitro of novel tetrahydroisoquinoline compounds based on the structure of lanosterol 14alpha-demethylase (CYP51) of fungi.
Zhu J; Lu J; Zhou Y; Li Y; Cheng J; Zheng C
Bioorg Med Chem Lett; 2006 Oct; 16(20):5285-9. PubMed ID: 16905318
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis.
Han G; Liu N; Li C; Tu J; Li Z; Sheng C
J Med Chem; 2020 May; 63(10):5341-5359. PubMed ID: 32347094
[TBL] [Abstract][Full Text] [Related]
19. In silico and in vitro screening to identify structurally diverse non-azole CYP51 inhibitors as potent antifungal agent.
Singh A; Paliwal SK; Sharma M; Mittal A; Sharma S; Sharma JP
J Mol Graph Model; 2016 Jan; 63():1-7. PubMed ID: 26579619
[TBL] [Abstract][Full Text] [Related]
20. Evolutionary trace analysis of CYP51 family: implication for site-directed mutagenesis and novel antifungal drug design.
Sheng C; Chen S; Ji H; Dong G; Che X; Wang W; Miao Z; Yao J; Lü J; Guo W; Zhang W
J Mol Model; 2010 Feb; 16(2):279-84. PubMed ID: 19593597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
